View:
United States securities and exchange commission logo
February 12, 2024
Troy Wilson, Ph.D., J.D.
President and Chief Executive Officer
Kura Oncology, Inc.
12730 High Bluff Drive, Suite 400
San Diego, CA 92130
Re: Kura Oncology, Inc.
Registration
Statement on Form S-3
Filed February 9,
2024
File No. 333-276995
Dear Troy Wilson:
This is to advise you that we have not reviewed and will not
review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Please contact Daniel
Crawford at 202-551-7767 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Wade Andrews, Esq.